Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial

PURPOSE: The purpose of this article is to investigate the efficacy and safety of frovatriptan plus dexketoprofen 25 or 37.5 mg (FroDex25 or FroDex37.5, respectively) compared to that of frovatriptan 2.5 mg (Frova) in menstrually related migraine (MRM). AIM: The aim of this article is to analyze a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Allais, G, Bussone, G, Tullo, V, Cortelli, P, Valguarnera, F, Barbanti, P, Sette, G, D’Onofrio, F, Curone, M, Benedetto, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261077/
https://www.ncbi.nlm.nih.gov/pubmed/25053749
http://dx.doi.org/10.1177/0333102414542290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261077/
https://www.ncbi.nlm.nih.gov/pubmed/25053749
http://dx.doi.org/10.1177/0333102414542290

Ejemplares similares